MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 154 filers reported holding MERSANA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,603 | -46.5% | 79,215 | +73.2% | 0.02% | -56.4% |
| Q1 2023 | $187,983 | -75.9% | 45,738 | -65.6% | 0.04% | -76.4% |
| Q4 2022 | $778,817 | +82.0% | 132,904 | +109.8% | 0.16% | +55.7% |
| Q3 2022 | $428,000 | +139.1% | 63,343 | +63.6% | 0.11% | +45.2% |
| Q2 2022 | $179,000 | +347.5% | 38,724 | +283.9% | 0.07% | +305.6% |
| Q1 2022 | $40,000 | -44.4% | 10,086 | -13.4% | 0.02% | -56.1% |
| Q4 2021 | $72,000 | -63.5% | 11,640 | -20.0% | 0.04% | -37.9% |
| Q2 2021 | $197,000 | – | 14,541 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |